FDA Approves Pombiliti Plus Opfolda for Late-Onset Pompe Disease
The unique, 2-component therapy improved walking ability and breathing function in the pivotal phase 3 clinical trial.
Source: everydayhealth.com
Stay updated with breaking news from Show Better Lung Function. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The unique, 2-component therapy improved walking ability and breathing function in the pivotal phase 3 clinical trial.